Stryker Corporation $SYK Shares Purchased by Larson Financial Group LLC

Larson Financial Group LLC boosted its position in Stryker Corporation (NYSE:SYK) by 10.4% in the 3rd quarter, Holdings Channel reports. The fund owned 16,404 shares of the medical technology company’s stock after purchasing an additional 1,539 shares during the period. Larson Financial Group LLC’s holdings in Stryker were worth $6,064,000 at the end of the most recent quarter.

Other institutional investors also recently bought and sold shares of the company. Armstrong Advisory Group Inc. boosted its holdings in shares of Stryker by 12.3% during the third quarter. Armstrong Advisory Group Inc. now owns 247 shares of the medical technology company’s stock worth $91,000 after purchasing an additional 27 shares during the last quarter. Venturi Wealth Management LLC increased its stake in Stryker by 1.4% in the third quarter. Venturi Wealth Management LLC now owns 1,904 shares of the medical technology company’s stock valued at $704,000 after purchasing an additional 27 shares during the last quarter. Patriot Financial Group Insurance Agency LLC increased its stake in Stryker by 3.9% in the third quarter. Patriot Financial Group Insurance Agency LLC now owns 745 shares of the medical technology company’s stock valued at $275,000 after purchasing an additional 28 shares during the last quarter. Wolff Wiese Magana LLC lifted its position in Stryker by 2.3% during the third quarter. Wolff Wiese Magana LLC now owns 1,271 shares of the medical technology company’s stock worth $470,000 after buying an additional 28 shares during the period. Finally, Enterprise Financial Services Corp lifted its position in Stryker by 4.3% during the second quarter. Enterprise Financial Services Corp now owns 705 shares of the medical technology company’s stock worth $279,000 after buying an additional 29 shares during the period. 77.09% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of analysts have issued reports on the company. UBS Group raised their price target on Stryker from $386.00 to $400.00 and gave the stock a “neutral” rating in a research note on Tuesday, February 24th. Sanford C. Bernstein increased their price objective on shares of Stryker from $450.00 to $465.00 and gave the stock an “outperform” rating in a report on Friday, January 9th. Raymond James Financial raised shares of Stryker from a “market perform” rating to an “outperform” rating and set a $418.00 target price on the stock in a research report on Tuesday, January 6th. TD Cowen downgraded shares of Stryker from a “buy” rating to a “hold” rating and set a $387.00 target price for the company. in a report on Monday, January 26th. Finally, Citigroup reaffirmed a “market outperform” rating on shares of Stryker in a research report on Friday, January 30th. Fourteen investment analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, Stryker currently has an average rating of “Moderate Buy” and an average price target of $428.61.

Stryker Stock Up 3.9%

Shares of Stryker stock opened at $349.89 on Tuesday. Stryker Corporation has a twelve month low of $328.23 and a twelve month high of $404.87. The stock has a market cap of $133.90 billion, a price-to-earnings ratio of 41.65, a price-to-earnings-growth ratio of 1.97 and a beta of 0.85. The company has a current ratio of 1.89, a quick ratio of 1.21 and a debt-to-equity ratio of 0.66. The company has a fifty day moving average price of $365.22 and a 200 day moving average price of $367.06.

Stryker (NYSE:SYK) last released its quarterly earnings data on Thursday, January 29th. The medical technology company reported $4.47 EPS for the quarter, beating the consensus estimate of $4.40 by $0.07. The company had revenue of $7.17 billion for the quarter, compared to analyst estimates of $7.12 billion. Stryker had a return on equity of 24.41% and a net margin of 12.92%.The firm’s revenue was up 11.4% compared to the same quarter last year. During the same period last year, the company posted $4.01 earnings per share. Equities research analysts forecast that Stryker Corporation will post 13.47 earnings per share for the current fiscal year.

Stryker Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, April 30th. Investors of record on Tuesday, March 31st will be issued a dividend of $0.88 per share. This represents a $3.52 annualized dividend and a dividend yield of 1.0%. The ex-dividend date is Tuesday, March 31st. Stryker’s dividend payout ratio (DPR) is presently 41.90%.

Insider Buying and Selling

In other Stryker news, Director Ronda E. Stryker sold 250,000 shares of the company’s stock in a transaction that occurred on Wednesday, February 4th. The stock was sold at an average price of $362.92, for a total value of $90,730,000.00. Following the completion of the transaction, the director owned 2,457,331 shares in the company, valued at $891,814,566.52. This represents a 9.23% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 5.20% of the company’s stock.

Stryker Company Profile

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.